Product Information
CLINDAMYCIN PHOSPHATE 1% FOAM is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $1.8305 per GM under NDC 45802066033. Its NADAC has been published 427 times since Nov 28, 2013.
FDA first approved this application on Mar 31, 2010. Its Orange Book therapeutic-equivalence code is AT.
Strength
10 mg/g
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802066033
Classification
Generic
Dosage Form
AEROSOL, FOAM
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
CLINDAMYCIN PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA090785FDA Approved
3/31/2010
TE Code
AT
On Market Since
3/31/2010
Pharmacological Classes
Price Statistics
The NADAC for CLINDAMYCIN PHOSPHATE 1% FOAM has been published 427 times since Nov 28, 2013, and over the history we have for it it has declined 36.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.8305 per GM |
|---|---|
| All-time high | $4.2831 (Dec 14, 2016) |
| All-time low | $1.8305 (Sep 23, 2026) |
| 52-week high | $3.4789 |
| 52-week low | $1.8305 |
| Median price | $3.6987 |
| Average price | $3.4458 |
| Largest weekly change | +17.8% (Feb 18, 2015) |
| Weeks tracked | 427 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Padagis Israel Pharmaceuticals Ltd manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
clindamycin phosphate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Lincosamide Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLINDAMYCIN PHOSPHATE 1% FOAM?
The current National Average Drug Acquisition Cost (NADAC) for CLINDAMYCIN PHOSPHATE 1% FOAM, manufactured by Padagis Israel Pharmaceuticals Ltd, is $1.8305 per GM (NDC 45802066033), effective Sep 30, 2026.
How has the price of CLINDAMYCIN PHOSPHATE 1% FOAM changed over time?
Over the history we have for it, the NADAC for CLINDAMYCIN PHOSPHATE 1% FOAM has declined 36.3%. It has been tracked across 427 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CLINDAMYCIN PHOSPHATE 1% FOAM?
Since Nov 28, 2013, the NADAC for CLINDAMYCIN PHOSPHATE 1% FOAM has ranged from a low of $1.8305 (Sep 23, 2026) to a high of $4.2831 (Dec 14, 2016), with a median of $3.6987 per GM.
Are there cheaper alternatives to CLINDAMYCIN PHOSPHATE 1% FOAM?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CLINDAMYCIN PHOSPHATE 1% FOAM in a comparable dosage form, but none are currently priced below it.
Who manufactures CLINDAMYCIN PHOSPHATE 1% FOAM?
CLINDAMYCIN PHOSPHATE 1% FOAM (NDC 45802066033) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.